Features of the metabolic syndrome and subclinical atherosclerosis in patients with cerebrotendinous xanthomatosis: An augmented risk for premature cardiovascular disease.

Cohen, H; Hassin-Baer, S; Shaish, A

Cohen, H; Hassin-Baer, S; Shaish, A.

Afiliação

Cohen H; The Bert W. Strassburger Metabolic Center, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
Hassin-Baer S; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel.
Shaish A; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel.

Front Genet ; 13: 997069, 2022.

Article em En | MEDLINE | ID: mdl-36238157

Palavras-chave

atherosclerosis; carotid intima-media thickness; cerebrotendinous xanthomatosis; cholestanol; coronary artery disease; low-density lipoprotein cholesterol; metabolic syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article